Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ASX/CBL stock hub

ASX/CBL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/CBLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
28M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/CBL
In the news

Latest news · ASX/CBL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-91.6
P25 -118.7P50 -49.4P75 -1.2
ROIC-50.8
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/CBL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
AUD
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Australia
Country code
AU
Enterprise value
AUD 25.2M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Medical Devices
Isin
AU0000114183
Last refreshed
2026-05-10
Market cap
AUD 28M
Price
AUD 0.07
Price currency
AUD
Sector
Healthcare
Sic
3842
Symbol
asx/CBL
Website
https://www.controlbionics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-23.19%
EV Earnings
-3.88x
EV/FCF
-5.64x
EV/Sales
4.15x
FCF yield
-15.94%
P/B ratio
3.62x
P/S ratio
4.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-99.73%
EBITDA Margin
-86.64%
Gross margin
62.85%
Gross Profit
AUD 3.8M
Gross Profit Growth
-7.28%
Gross Profit Growth Q
-17.84%
Gross Profit Growth3 Y
-0.71%
Gross Profit Growth5 Y
0.55%
Net Income
AUD -6.5M
Net Income Growth Years
0%
Pretax Margin
-107.04%
Profit Margin
-107.04%
ROA
-40.3
Roa5y
-30.72
ROCE
-77.87
ROE
-91.56
Roe5y
-64.79
ROIC
-50.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
97.76%
Cagr3y
-17.17%
Cagr5y
-35.65%
EPS Growth Quarters
7
EPS Growth Years
3
Revenue Growth
14.88x
Revenue Growth Q
-2.63x
Revenue Growth Years
1x
Revenue Growth3 Y
4.29x
Revenue Growth5 Y
1.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
AUD 0.65
Assets
AUD 9.9M
Cash
AUD 3.1M
Current Assets
AUD 4.8M
Current Liabilities
AUD 2.2M
Debt
AUD 238,271
Debt Equity
AUD 0.03
Debt FCF
AUD -0.05
Equity
AUD 7.7M
Interest Coverage
-61.87
Liabilities
AUD 2.2M
Long Term Assets
AUD 5.1M
Long Term Liabilities
AUD 43,037
Net Cash
AUD 2.8M
Net Cash By Market Cap
AUD 10.06
Net Cash Growth
443.28%
Net Debt Equity
AUD -0.36
Tangible Book Value
AUD 3.1M
Tangible Book Value Per Share
AUD 0.01
WACC
4.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.22
Inventory Turnover
4.71
Net Working Capital
AUD -211,471
Quick ratio
1.98
Working Capital
AUD 2.6M
Working Capital Turnover
AUD 3.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-41.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
97.66%
200-day SMA
0.05
3Y total return
-43.18%
50-day SMA
0.06
50-day SMA vs 200-day SMA
50over200
5Y total return
-88.96%
All Time High
1.24
All Time High Change
-94.52%
All Time High Date
2020-12-07
All Time Low
0.03
All Time Low Change
161.54%
All Time Low Date
2025-06-20
ATR
0
Beta
0.07
Beta1y
-0.01
Beta2y
-0.71
Ch YTD
11.48
High
0.07
High52
0.09
High52 Date
2025-11-11
High52ch
-20.93%
Low
0.07
Low52
0.03
Low52 Date
2025-06-20
Low52ch
161.54%
Ma50ch
15.84%
Price vs 200-day SMA
33.6%
RSI
65.62
RSI Monthly
45.65
RSI Weekly
58.27
Sharpe ratio
0.78x
Sortino ratio
1.55
Total Return
-41.23%
Tr YTD
11.48
Tr1m
13.33%
Tr1w
21.43%
Tr3m
21.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -6.1M
Operating margin
-99.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
138,555,267%
Net Borrowing
-266,345
Shares Insiders
15.13%
Shares Institutions
4.93%
Shares Out
411,961,889
Shares Qo Q
11.73%
Shares Yo Y
41.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
AUD -4.6M
Average Volume
331,596.2x
Bv Per Share
0.02
CAPEX
AUD -337,990
Ch1m
13.33
Ch1w
21.43
Ch1y
94.29
Ch3m
21.43
Ch3y
-49.63
Ch5y
-90.22
Ch6m
70
Change
4.62%
Change From Open
4.62
Close
0.07
Days Gap
0
Depreciation Amortization
794,050
Dollar Volume
18,866.1
Earnings Date
2026-05-26
EBIT
AUD -6.1M
EBITDA
AUD -5.3M
EPS
AUD -0.02
F Score
2
FCF
AUD -4.5M
FCF EV Yield
-17.72x
FCF Per Share
AUD -0.01
Financing CF
6,925,993
Fiscal Year End
June
Founded
2,005
Goodwill
752,097
Investing CF
-704,368
Is Primary Listing
1
Last Earnings Date
2026-02-23
Last Report Date
2025-12-31
Ma150
0.06
Ma150ch
21.21%
Ma20
0.06
Ma20ch
11.84%
Net CF
2,084,317
Next Earnings Date
2026-05-26
Open
0.07
Position In Range
100
Ppne
559,772
Price Date
2026-05-08
Ptbv Ratio
8.91
Relative Volume
0.85x
Revenue
6,068,660x
SBC By Revenue
2.04x
Share Based Comp
123,872
Tr6m
70%
Volume
277,443
Z Score
-2.63
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/CBL pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CBL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+97.7%
S&P 500 1Y: n/a
3Y total return
-43.2%
S&P 500 3Y: n/a
5Y total return
-89.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ASX/CBL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.9%
Share of float held by funds and institutions
Insider ownership
+15.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+41.2%
Negative means the company is buying back shares.
Technical

ASX/CBL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
65.6
Neutral momentum band
Price vs 200-day MA
+33.6%
50/200-day relationship not available
Beta (5Y)
0.07
Less volatile than the market
Sharpe ratio
0.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/CBL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CBL stock rating?

asx/CBL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CBL analysis?

The full report lives at /stocks/asx/CBL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CBL?

The latest report frames asx/CBL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CBL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.